C.T. Fitzpatrick
Vulcan Value Partners
Vulcan Value Partners Portfolio 13F
Vulcan Value Partners Holdings Activity
- Portfolio value:
- $11.58B≈ (+$356M≈)
- Previous value:
- $11.23B≈
- # of changes:
- 59
- New positions:
- 5
- Reported for:
- 31 Mar 2017 (Q1)
- Latest filing date:
- 15 May 2017
Vulcan Value Partners has disclosed a total of 59 changes to the portfolio in the (2017 Q1) SEC report(s): increased the number of shares of 22, bought 5 totally new, decreased the number of shares of 28 and completely sold out 4 position(s).
What stocks did Vulcan Value Partners buy in 2017 Q1?
During 2017 Q1 Vulcan Value Partners has bought 27 securities out of which top 5 purchases (by % change to portfolio) were (ORCL) Oracle Corp (added shares +0.33%), (NOV) NOV Inc (added shares +1.19%), (CVS) CVS Health Corp (added shares +42.22%), (MA) Mastercard Inc (added shares +1.10%) and (DISCK) Discovery Inc (added shares +0.29%).
In the 2017 Q1 report(s) the following changes have been made to the top investments: (ORCL) Oracle Corp (added shares +0.33%), (NOV) NOV Inc (added shares +1.19%), (CVS) CVS Health Corp (added shares +42.22%), (MCK) McKesson Corp (reduced shares -1.74%) and (COR) Cencora Inc (reduced shares -2.05%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.